Milestones in NSCLC

Welcome to the Resource Center “Milestones in Non-Small-Cell Lung Cancer (NSCLC)” launched by Elsevier and the Journal of Thoracic Oncology at the World Conference on Lung Cancer 2016 in Vienna.

Recent years have seen much progression in learning about the biology of lung cancer cells and the mechanisms that control their growth and spread. This has led to define biomarkers and oncogenic drivers, to develop new screening systems such as liquid biopsy and improving patients outcome with targeted strategies and immunotherapies.

The Resource Center “Milestones in NSCLC” is dedicated to providing you with groundbreaking discoveries in diagnosis and management of NSCLC. Our aim is to supply health care professionals with clinically relevant information to enhance knowledge about lung cancer and help meet the challenges faced in today’s medical practice.

Article of the month

  • Programmed Cell Death Ligand (PD-L1) Expression in Stage II and III Lung Adenocarcinomas and Nodal Metastases

    Hironori Uruga MD, PhD, Emine Bozkurtlar MD, Tiffany G. Huynh BA, Alona Muzikansky MA, Yasushi Goto MD, PhD, Maria Gomez-Caraballo BA, Aaron N. Hata MD, PhD, Justin F. Gainor MD, Eugene J. Mark MD, Jeffrey A. Engelman MD, PhD, Michael D. Lanuti MD, Mari Mino-Kenudson MD

    Journal of Thoracic Oncology, Volume 12, Issue 3, March 2017, Pages 458 - 466

    Commentary by Stefan Zimmermann

    Will you find similar levels of PD-L1 expression in nodal metastases and in the primary tumor?...


New this month

Pages


PILC 2017, Madrid – Webcast on Demand

Debating the optimal management in advanced and metastatic lung cancer: The right treatment for the right patient at the right time: ​How I optimize treatment for my NSCLC patients with advanced and aggressive disease

Missed the event or would you like to rewatch what the speakers had to tell.


ECCO 2017, Amsterdam - Webcasts on Demand

Debating the optimal management in advanced and metastatic lung cancer: The right treatment for the right patient at the right time

Missed the event or would you like to rewatch what the speakers had to tell.

Stay informed

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Made possible by an educational grant from

Please note that Lilly Oncology has no editorial control over the content of this Resource Centre. The Resource Centre and all content therein has been subjected to an independent editorial review.

Perspectives in Lung Cancer 2017

How I optimize treatment for my NSCLC patients with advanced and aggressive disease


Now available: Webcast on demand


 

ECCO 2017

Debating the optimal management in advanced and metastatic lung cancer: The right treatment for the right patient at the right time


Did you miss the Satellite Symposium?

Now available: Webcast on demand


This educational activity is provided by Elsevier. Independent sponsorship for this educational activity was provided by Lilly Oncology.

Interactive Case Reports

Read more about recent cases from the Journal of Thoracic Oncology. Test your knowledge and answer the questions following the case to get immediate feedback.

Solange Peters

Editor in Chief

Tom Stinchcombe

Advisory Editor

Nir Peled

Advisory Editor

Stefan Zimmermann

Managing Editor

About the Editors

All content available on the Milestones in NSCLC Resource Centre, including original and review articles, interviews, guidelines, congress highlights, case reports is independently selected by the members of the Editorial Board.